Temozolomide 82249-0410
Product NDC
82249-0410- Manufacturer
- Civicascript Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 28, 2017
- Listing Expires
- December 31, 2027
- Application
- ANDA207658
Need to source Temozolomide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Temozolomide | 140 mg/1 |
Drug Class
Alkylating Drug [EPC]Alkylating Activity [MoA]Alkylating Drug [EPC]
Packaging Options(2)
5 CAPSULE in 1 BOTTLE (82249-410-05)
14 CAPSULE in 1 BOTTLE (82249-410-14)